Effects of bilirubin on alveolar macrophages in rats with emphysema and expression of iNOS and NO in them

Abstract

To explore the effects of bilirubin on alveolar macrophages (AM) and expression of iNOS and NO in them in emphysema model, the rats were pretreated with bilirubin before exposed to smoke. AM were isolated from bronchoalveolar lavage fluid (BALF) and cultured. Pathological microscopic examination of AM and immunohistochemical analysis of iNOS were performed. Nitric oxide (NO) content in the samples was determined by nitrate reductase technique. The results showed both alveoli and alveolar septum appeared normal in size and shape in normal group. AM showed kidney-shaped nucleus and were rich in Golgi complexes and primary lysosomes in the cytoplasm. The inner membrane of mitochondrion was continuous. Most cristae of the mitochondria were intact. In model group, the alveoli were expanded, ruptured and bullaes were formed. Both the population and sizes of AM increased significantly. Secondary lysosomes were rich in the cytoplasm. Deformation and pyknosis of the nucleus, swelling of the mitochondrions and rupture of the inner mitochondrial membrane could also be seen. At high magnification, most of the mitochondrial cristae were broken, or completely lost at certain points. In bilirubin group, alveoli partly expanded and the population of AM also increased, with morphological changes being slighter than that in model group. Both NO contents and expression of iNOS in model group were higher than those in normal group (P<0.05). In bilirubin group the two indice were lower than those in model group (P<0.05). Our findings suggested that high expression of iNOS and high NO content in AM accelerate the development of emphysema associated with smoking in rats. Bilirubin may exert protective effects on AM and retards the development of emphysema in rats.

Keywords

bilirubin / emphysema / alveolar macrophage

References

[1] ClarkJ E, ForestiR, SarathchandraP, et al. . Heme oxygenase-l-devided bilirubin ameliorates postischemic myocardial dysfunction. Am J Physiol Heart Circ Physiol, 2000, 278H643-H643

[2] OssiaJ O, TomaroM L. Heme oxygenase induction by HVA radiation. A response to oxidative stress in rat liver. Int J Biochem Cell Biol, 1998, 30285-285

[3] XuS L, WuR L, ChenC L, et al. . The study of E-card herin expression on injury and repair of epithelium of respiratory tract in smoking mice (Chinese). Chin J Tuher Respir Dis, 1999, 22(7): 417-417

[4] Chinese Society of Respiratory Diseases under CMA. Bronchealveolar iavage and technical specifications of cytometry in larvage (Chinese). Chin J Tuber Respir Dis, 1994, 17(1): 10-10

[5] KisalaJ M, AyalaA, StephanR N, et al. . A model of pulmonary atelectasis in rats: activation of alveolar macrophage and cytokine release. Am J Physiol, 1993, 264610-610

[6] MaryJ T, LisaT D, CharlesJ F. Regulation of human alveolar macrophage inflammatory cytokine production by interleukin-10. Clin Immunol Immunopathol, 1996, 80321-321

[7] SchwertnerH A. Association of smoking and low serum bilirubin antioxidant concentrations. Atherosclerosis, 1998, 136383-383

[8] StockerR, YamamotoY, DonaghMC, GlazerAF. Bilirubin is an antioxidant of possible physiological importance. Science, 1987, 2351043-1043

[9] NazirogluM, CayM, UstundagB. Protective effects of vitamin E on carbon tetrachloride-induced liver damage in rats. Cell Biochem Funct, 1999, 17253-253

[10] SiowR C M, SatoH, LeakeD S, et al. . Vitamin C protects human arterial smooth muscle cells against atherogenic lipoproteins: Effects of antioxidant vitamins C and E on oxidized LDL-induced adaptive increases in cystine transport and glutathione. Arterioscler Thromb Vasc Biol, 1998, 181662-1662

[11] StockerR, GlaxevA N, AmesB N. Antioxidatant activity of albumin-bound bilirubin. Proc Natl Acad Sci USA, 1987, 845919-5919

[12] BrielandJ K, FloryC M, JonesM L, et al. . Regulation of monocyte chemoattractant protein-1 gene expression and secretion in rat pulmonary alveolar macrophages by lipoplysaccharide, tumor necrosis factor-alpha, and interleukin-1 beta. Am. J Respir. Cell Mol Biol, 1995, 12(1): 104-104

[13] StevenS D. The macrophage in chronic obstructive pulmonary disease. Am J Respir Crit Care Med, 1999, 16029-29

[14] MausU, RosseauS, KniesU, et al. . Expression of proinflammatory cytokines by flow-sorted alveolatr macrophage in severe pneumonia. Eur Respir J, 1998, 11(3): 534-534

[15] Wurzel, YehC C, ZairolaC, et al. . Oxidative damage and antioxidant status in the lungs and bronchoalveolar lavage fluid of rats exposed chronically to cigarette smoke. J Biochem Toxicol, 1995, 10(1): 11-11

[16] SinghS, EvansT W. Nitric Oxide, the biological mediate of the decade: fact or fiction. Eur Respir J, 1997, 10(3): 699-699